Combined treatment with propranolol and anti-PD-1 blockade (RMP1-14) is associated with decreased PD-1 expression in CD8+ TILS and decreased tumor growth in the 4T1 murine tumor model (9). This evidence concerns the gene PDCD1 and neoplasm.